Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Climacteric : the Journal of the International Menopause Society|June 29, 2001
Tibolone and its effects on bone: a reviewB Berning, H J Bennink, B C FauserMaturitas|May 10, 2000
Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal womenB Berning, C van Kuijk, H J Bennink, et al.Bone|October 1, 1996
Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled studyB Berning, C V Kuijk, J W Kuiper, et al.Maturitas|May 5, 1999
Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with TiboloneB Berning, C van Kuijk, J W Kuiper, et al.Bone and Mineral|May 1, 1993
Determinants of lumbar bone mineral density in normal weight, non-smoking women soon after menopause. A study using clinical data and quantitative computed tomographyB Berning, C van Kuijk, H E Schütte, et al.Human Reproduction (Oxford, England)|July 1, 1994
Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient womenD C Schoot, J Harlin, Z Shoham, et al.Human Reproduction Update|March 1, 1997
Follicular development and oocyte maturation in hypogonadotrophic women employing recombinant follicle-stimulating hormone: the role of oestradiolB C FauserHuman Reproduction (Oxford, England)|October 2, 1998
Developments in human recombinant follicle stimulating hormone technology: are we going in the right direction?B C FauserJournal De Gynecologie, Obstetrique Et Biologie De La Reproduction|May 1, 2002
[Role of LH in ovarian stimulation: present and future]B C FauserMolecular Human Reproduction|May 1, 1996
Interference with follicle stimulating hormone regulation of human ovarian functionB C FauserPageof 14